Top Markets
#1 PulseChain PulseChain +43.68%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.51%
#3 Bitcoin SV Bitcoin SV +4.90%
#4 Fake World Assets Fake World Assets +4.35%
#5 eCash eCash +3.82%
#6 Shuffle Shuffle +3.57%
#7 Magma Finance Magma Finance +3.00%
#8 HOME HOME +2.48%
#9 AI XOVIA AI XOVIA +2.28%
#10 Morpho Morpho +2.27%
Coin of the day
PulseChain PulseChain
設定
言語
日本
通貨
USD
テーマ
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
株式のランク #29363
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
株価
$0.365
最終同期: 2025-08-01
時価総額
$21.54M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Elevation Oncology, Inc. (ELEV)

カテゴリー

Healthcare
Elevation Oncology, Inc.（ELEV）のEPS
2026 時点のEPS TTM: 0
Elevation Oncology, Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Elevation Oncology, Inc.のEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH